IPC Flags on Adverse Reaction Linked To Antihypertensive Drug Losartan

Published On 2022-03-04 13:54 GMT | Update On 2023-10-11 10:37 GMT

The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of February, has revealed that popular antihypertensive drug, Losartan is linked with Adverse Drug Reactions (ADRs), Muscle Spasm.

This came after preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database.

For more information check out the full story on the link below: Indian Pharmacopoeia Commission, IPC, Adverse Drug Reactions ,ADRs, PvPI,database

IPC flags adverse reaction linked to antihypertensive drug Losartan

Full View

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Roshni Dhar

Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

IPC Flags on Adverse Reaction Linked To Antihypertensive Drug Losartan

Similar News